Extract

In our recent editorial we discussed the difficulties related to the prevention of malaria in international pediatric travelers, in general, and in pediatric travelers visiting friends and relatives specifically. 1 We highlighted many travel medicine logistical obstacles that result in significant risk for children who travel to malaria‐endemic regions. A pivotal need when traveling to a high risk malaria‐endemic area is to have a safe, efficacious, and acceptable prophylactic antimalarial drug. If parents are required to sign a special consent form before the prescription for an antimalarial can be issued, this will complicate procedures and will hinder the acceptance and adherence to the drug regimen. We would like to thank Drs Takeshita and Kanagawa for sharing, with us, this important reality of pretravel care for children in Japan. 2 It is noteworthy that the Pediatrics Interest Group within the International Society of Travel Medicine was just constituted and met at the recent CISTM meeting in Boston for the first time. 3 It is our hope that this renewed focus on pediatric travel medicine will help advocate for an improved and easy access of children to competent pretravel care and efficacious antimalarial drugs for prophylaxis.

You do not currently have access to this article.